The Brain Health Study: A Pragmatic, Patient-Centered Trial

a study on Dementia Alzheimer's Disease

Summary

Eligibility
for people ages 65 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Deborah Barnes, PhD

Description

Summary

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Official Title

Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the Electronic Health Record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Algorithm in a Pragmatic, Patient-centered Trial.

Details

Detailed description: eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. The investigators will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. The investigators will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

Keywords

Dementia, Alzheimer Disease, Brain Health Assessment

Eligibility

You can join if…

Open to people ages 65 years and up

  • No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
  • Active patient at participating clinic
  • Adequate data to calculate eRADAR score

You CAN'T join if...

- Currently receiving hospice care

Locations

  • UCSF Primary Care at China Basin not yet accepting patients
    San Francisco California 94107 United States
  • Women's Health Primary Care accepting new patients
    San Francisco California 94143 United States
  • Division of General Internal Medicine not yet accepting patients
    San Francisco California 94115 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05905796
Study Type
Interventional
Participants
Expecting 1350 study participants
Last Updated
Contact us about this trial